Premature Ejaculation Clinical Trial
— GETUPOfficial title:
Consultations Reason for Genital, Urinary or Psychological Humans in General Practice
NCT number | NCT02378779 |
Other study ID # | GETUP |
Secondary ID | |
Status | Terminated |
Phase | N/A |
First received | |
Last updated | |
Start date | April 22, 2016 |
Est. completion date | April 22, 2018 |
Verified date | October 2020 |
Source | University Hospital, Brest |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Many male patients complain about their ejaculation: 21-30% of men aged between 18 and 59 have admitted suffering from a decrease in, or loss of control of, their ejaculation. The quality of life of patients and their partners is impaired compared to men not suffering from premature ejaculation. Economically, the impact of the disease are significant. In the year preceding the detection of premature ejaculation patients visit twice their physician. The majority of men interviewed anonymously, in their General Practitioner's ( GP's) waiting room, considered it important to talk with their GP about their sexual concerns. Almost half of them preferred that their GP initiate any discussions about sexuality. More than two thirds of the respondents would have liked their GP to signal his or her open-mindedness by directly addressing sexual topics during the consultation. In 2008 a qualitative study brought to the fore the strategies used by GPs to initiate the discussion on premature ejaculation . GPs who mentioned premature ejaculation with their patient described three attitude-related strategies and three investigative strategies.
Status | Terminated |
Enrollment | 132 |
Est. completion date | April 22, 2018 |
Est. primary completion date | April 22, 2018 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Male patients overbetween 18 and 80 years old and - Patients consulting for a sexual, urogenital or psychological reason according to Interntational Classification of Primary Care (ICPC-2) will be included. Exclusion Criteria: - Patients consulting for Aanother reason for visiting thethan urogenital pattern, sexual or psychological - Nonunderstanding of the French language - Patients with psychiatric disorders affecting judgement - Patient refusal to participate in the study |
Country | Name | City | State |
---|---|---|---|
France | Cabinet médical | Ambert | |
France | Cabinet médical - 89 Bis Rue de la Calade | Assas | |
France | Cabinet médical | Augerolles | |
France | Cabinet médical | Avermes | |
France | Cabinet médical - Esplanade Mitterrand 5 | Bellerive-sur-Allier | |
France | Cabinet de médecine générale | Brest | |
France | Cabinet du 122 rue Paul Masson | Brest | |
France | Cabinet médical Place J. London | Brest | |
France | Cabinet médical | Clarensac | |
France | Cabinet médical | Fleury | |
France | Pôle universitaire de Lanmeur | Lanmeur | |
France | Cabinet médical | Le Mayet de Montagne | |
France | Cabinet médical | Le Puy En Velay | |
France | Cabinet médical | Lempdes sur Allagnon | |
France | Cabinet médical du 38 Bd 1848 | Narbonne | |
France | Cabinet de médecine générale | Ondres | |
France | Cabinet de médecine générale | Pont de Buis Les Quimerch | |
France | Cabinet médical du 5 Descente des Oliviers | Restinclières | |
France | Cabinet médical | Saint Nicolas du Pelem | |
France | Groupe médical Tourren | Saint Vincent de Tyrosse | |
France | Cabinet de médecine générale | Saubrigues | |
France | Cabinet médical | Thézan Les Béziers | |
France | Cabinet médical - 39 rue Saint Philibert | Trégunc |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Brest |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The impact of training general practitioners in communication skills | The impact of training general practitioners in communication skills on the rate of patients bringing up the topic of premature ejaculation with their GP. To measure the proportions of patients bringing up the topic of premature ejaculation with their GP, the GPs in the two groups were asked to fill in a questionnaire after the consultation on whether the topics tackled were genital, urinary or psychological. The aim of detailing the different topics broached was to avoid contamination bias in the control group. | Day 0 - 4 weeks | |
Secondary | Evaluation of quality of life | The quality of life will be evaluated with the SF-12 health assessment scale. The SF-12 was designed to measure general health status from the patient's point of view. The SF-12 includes 8 concepts commonly represented in health surveys: physical functioning, role functioning physical, bodily pain, general health, vitality, social functioning, role functioning emotional, and mental health. | Day 0 - 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02232425 -
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
|
Phase 2 | |
Completed |
NCT01439984 -
Trial of PED-1 in Male Patients With Premature Ejaculation
|
Phase 3 | |
Completed |
NCT01184105 -
A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation
|
Phase 1 | |
Completed |
NCT01203202 -
Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation
|
Phase 2 | |
Completed |
NCT03942367 -
Evaluation of the Safety and Effectiveness of the vPatch Device
|
N/A | |
Recruiting |
NCT06425211 -
Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation.
|
N/A | |
Completed |
NCT02939495 -
The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy
|
Phase 4 | |
Completed |
NCT02572037 -
Research and Clinical Value of New Classification for Premature Ejaculation: Multi-Center Research
|
||
Recruiting |
NCT02581826 -
Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation
|
Phase 2 | |
Terminated |
NCT00983736 -
Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation
|
Phase 3 | |
Completed |
NCT00556478 -
Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation
|
Phase 2/Phase 3 | |
Completed |
NCT00549211 -
A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.
|
Phase 1 | |
Not yet recruiting |
NCT05556083 -
Sildenafil Added Effect in Dapoxetine Non-responding Mono-symptomatic Premature Ejaculation (PE)
|
Phase 2 | |
Completed |
NCT03304808 -
Efficacy of a New Behavioral Treatment for Premature Ejaculation Using a Masturbation Aid Device: Star-Stop 3.0
|
N/A | |
Completed |
NCT00861484 -
Proof of Mechanism in ELT
|
Phase 1 | |
Completed |
NCT02984592 -
Effect of Exercise on Premature Ejaculation
|
N/A | |
Recruiting |
NCT02571101 -
A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation
|
Phase 2 | |
Completed |
NCT03174470 -
Safety Demonstration of Increasing Intensities of Electrical Stimulation Delivered to The Bulbospongiosus Muscle
|
N/A | |
Completed |
NCT02794454 -
A Study to Evaluate Efficacy of Investigational Product HeezOn Ultra -1/ HeezOn Ultra-2 on Male Sexual Health
|
N/A | |
Completed |
NCT02297152 -
A New Treatment for Premature Ejaculation?
|
N/A |